Targeted disruption of the tumor necrosis factor-alpha gene - Metabolic consequences in obese and nonobese mice

被引:234
作者
Ventre, J
Doebber, T
Wu, M
MacNaul, K
Stevens, K
Pasparakis, M
Kollias, G
Moller, DE
机构
[1] MERCK RES LABS,DEPT MOL ENDOCRINOL,RAHWAY,NJ 07065
[2] MERCK RES LABS,DEPT LAB ANIM RESOURCES,RAHWAY,NJ 07065
[3] HELLENIC PASTEUR INST,ATHENS,GREECE
关键词
D O I
10.2337/diabetes.46.9.1526
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To address the hypothesis that tumor necrosis factor (TNF)-alpha has a role in obesity-associated insulin resistance or the regulation of in vivo lipid metabolism, mice with targeted disruption of the TNF-alpha gene were generated and studied. The absence of TNF-alpha protein in TNF-null (-/-) mice was confirmed. Lean or obese (gold-thioglucose [GTG]-injected) homozygous (-/-) mice were compared with lean or obese age-and sex-matched wild-type (+/+) mice derived from the same line at 13, 19, and 28 weeks of age. The following parameters were significantly affected in lean -/- versus +/+ mice: Body weight was not affected until week 28 (decreased by 14%); epididymal fat pad weight also decreased (25%) at this time, as did percentage body fat (16%), while percentage body protein was increased 13%. Fed plasma insulin levels decreased 47% (28 weeks), triglyceride levels decreased (all three ages; maximum 35% at 19 weeks), and fed plasma leptin decreased 33% (28 weeks). Fasting glucose was slightly (10%) reduced, but the glucose response to an oral glucose tolerance test (OGTT) was not affected. There was a trend (NS) toward increased total adipose tissue lipoprotein Lipase in -/- versus +/+ mice. GTG-treatment resulted in obese -/- and +/+ mice with equal mean body weights (42 and 58% increased weight versus lean mice). The following parameters were significantly different in obese -/- mice: fasting plasma glucose decreased 13% (28 weeks), fed plasma insulin decreased 67% (28 weeks), and insulin response to OGTT was decreased by 50%. For both groups of obese mice, glucose levels during the OGTT were substantially increased compared with those in lean mice; however, mean stimulated glucose levels were 20% lower in obese -/- versus +/+ mice. We conclude 1) that TNF-alpha functions to regulate plasma triglycerides and body adiposity and 2) that although TNF-alpha contributes to reduced insulin sensitivity in older or obese mice, the absence of TNF-alpha is not sufficient to substantially protect against insulin resistance in the GTG hyperphagic model of rodent obesity.
引用
收藏
页码:1526 / 1531
页数:6
相关论文
共 23 条
[1]   CACHECTIN (TUMOR NECROSIS FACTOR) - A MACROPHAGE HORMONE GOVERNING CELLULAR-METABOLISM AND INFLAMMATORY RESPONSE [J].
BEUTLER, B ;
CERAMI, A .
ENDOCRINE REVIEWS, 1988, 9 (01) :57-66
[2]  
DOEBBER TW, 1996, DIABETES S2, V45, pA92
[3]  
FEINSTEIN R, 1993, J BIOL CHEM, V268, P26055
[4]   Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate 1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes [J].
Guo, DQ ;
Donner, DB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :615-618
[5]   Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein [J].
Hotamisligil, GS ;
Johnson, RS ;
Distel, RJ ;
Ellis, R ;
Papaioannou, VE ;
Spiegelman, BM .
SCIENCE, 1996, 274 (5291) :1377-1379
[6]   TUMOR-NECROSIS-FACTOR-ALPHA - A KEY COMPONENT OF THE OBESITY-DIABETES LINK [J].
HOTAMISLIGIL, GS ;
SPIEGELMAN, BM .
DIABETES, 1994, 43 (11) :1271-1278
[7]   IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance [J].
Hotamisligil, GS ;
Peraldi, P ;
Budavari, A ;
Ellis, R ;
White, MF ;
Spiegelman, BM .
SCIENCE, 1996, 271 (5249) :665-668
[8]   ADIPOSE EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA - DIRECT ROLE IN OBESITY-LINKED INSULIN RESISTANCE [J].
HOTAMISLIGIL, GS ;
SHARGILL, NS ;
SPIEGELMAN, BM .
SCIENCE, 1993, 259 (5091) :87-91
[9]   INCREASED ADIPOSE-TISSUE EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA IN HUMAN OBESITY AND INSULIN-RESISTANCE [J].
HOTAMISLIGIL, GS ;
ARNER, P ;
CARO, JF ;
ATKINSON, RL ;
SPIEGELMAN, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2409-2415
[10]   Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1 [J].
Kanety, H ;
Hemi, P ;
Papa, MZ ;
Karasik, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (17) :9895-9897